ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RGC vs MO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Regencell Bioscience Holdings Limited (NASDAQ) VS. Altria Group Inc. (NYSE) • 15-METRIC TALLY: RGC 0 — MO 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RGC VS. MO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RGC MO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 62.50% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 48.40% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 14.7x — TIE /valuation <GO>
Free Cash Flow Yield -0.10% 7.08% -7.18 MO /fcf-yield <GO>
Operating Margin — 42.50% — TIE /operating-margins <GO>
Net Profit Margin — 29.80% — TIE /net-margins <GO>
Revenue Growth (YoY) — -3.10% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 5.43% -5.43 MO /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.90 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 6/9 -4.00 MO /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.1 63.7 -19.60 MO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.92 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 17.1x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.40B $128.15B -$124.75B MO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RGC REV MO REV RGC GROSS % MO GROSS % RGC FCF MO FCF
FY 2025 $0 $23.28B — 62.5% -$3.3M $9.07B
FY 2024 $0 $24.02B — 59.8% -$4.0M $8.61B
FY 2023 $0 $24.48B — — -$5.0M $8.19B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RGC // BETA —
MO // BETA 0.92